Shinhan Life Submits 2025 Audit Report, Adopts New K-IFRS 1117 Policy for Insurance Liabilities
Summary
Shinhan Life submitted its 2025 audit report, revealing mixed financial results for the Group, including a decline in net profit and a significant drop in equity, alongside a retrospective accounting policy change for insurance liabilities.
Key Events
-
Shinhan Life 2025 Audit Report Submitted
Shinhan Financial Group's wholly-owned subsidiary, Shinhan Life, has submitted its audited financial reports for the fiscal year ended December 31, 2025.
-
Mixed Financial Performance for the Group
Consolidated operating profit increased by W 66,906 million to W 791,988 million, but profit for the period decreased by W 20,693 million to W 507,708 million.
-
Significant Decrease in Total Equity
Total equity decreased by W 834,303 million to W 6,206,398 million, mainly due to annual dividend payments, changes in discount rate assumptions, and other regulatory effects.
-
Retrospective Accounting Policy Change
The Group adopted K-IFRS No. 1117 for participating insurance contracts, discontinuing a prior 'accounting departure.' This change was applied retrospectively, impacting prior period liabilities and equity.
Analysis
Shinhan Financial Group's wholly-owned subsidiary, Shinhan Life, has submitted its audited financial reports for fiscal year 2025. The Group reported mixed consolidated financial results, with operating profit increasing by W 66,906 million to W 791,988 million, but profit for the period decreased by W 20,693 million to W 507,708 million. Total equity saw a substantial decrease of W 834,303 million, primarily due to annual dividend payments, changes in discount rate assumptions, and other regulatory effects. A significant accounting policy change was also implemented, discontinuing a prior 'accounting departure' for participating insurance contracts to fully comply with K-IFRS No. 1117. This change was applied retrospectively, resulting in a W 362 million decrease in liabilities and equity for 2024, and a W 1,025 million decrease for the January 1, 2024, opening balance. These financial statements are still subject to shareholder approval.
At the time of this filing, SHG was trading at $65.50 on NYSE in the Finance sector, with a market capitalization of approximately $30.7B. The 52-week trading range was $28.76 to $73.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.